Kinetics and dynamics of single oral doses of sirolimus in sixteen renal transplant recipients

Therapeutic Drug Monitoring

Volumn 19, Issue 4, 1997, Pages 397-406

  Brattström, Christina ^a   Säwe, Juliette ^a   Tydén, Gunnar ^a   Herlenius, Gustaf ^a   Claesson, Kerstin ^a   Zimmerman, James ^b   Groth, Carl Gustav ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Clinical Pharmacology Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; AZATHIOPRINE; CYCLOSPORIN A; LIVER ENZYME; PLACEBO; PREDNISOLONE; RAPAMYCIN;

ADULT; AMYLASE BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERANCE; EPISTAXIS; FEMALE; HEADACHE; HUMAN; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; THROMBOCYTOPENIA; VERTIGO;

ADMINISTRATION, ORAL; ADULT; AGED; CYCLOSPORINE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PLACEBOS; POLYENES; SIROLIMUS;

EID: 0344074657     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199708000-00007     Document Type: Article

References (27)

1. Calne R, Lim S, Samaan A, Collier SJ, Pollars SG, White DJG. Rapamycin for immunosuppression of organ allografting. Lancet 1989;2:227.
2. Morris RE, Wu J, Shorthouse R. A study of the contrasting effects of cyclosporine, FK 506 and rapamycin on the suppression of allograft rejection. Transplant Proc 1990;22:1638.
3. Morris RE, Meiser BM. Identification of a new pharmacologic action for an old compound. Med Sci Res 1989;17:609-610.
4. Stepkowski SM, Chen H, Daloze P, Kahan BD. Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney and small bowel transplantation in the rat. Transplantation 1991;51:22-26.
5. Vathsala A, Chou TC, Kahan BD. Analysis of the interaction of immunosuppressive drugs with cyclosporine in inhibiting DNA proliferation. Transplantation 1990;49:463-72.
6. Collier DS, Calne RY, Pollard SG, Friend PJ, Thiru S. Rapamycin in experimental renal allografts in primates. Transplant Proc 1991;23:2246-2247.
7. Adams LM, Caccese R, Cummons T, et al. Effect of the immunosuppressants rapamycin (Rap) and cyclosporine A (CsA) on collagen-induced arthritis (CIA) in mice. J Cell Biol 1989;109:163a.
8. Tocci MJ, Matkovich DA, Collier KA, et al. The immunosuppressant FK 506 selectively inhibits expression of early T-cell activation genes. J Immunol 1989;143:718-726.
9. Metcalfe SM, Richards FM. Cyclosporine, FK 506, and rapamycin: some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells. Transplantation 1990;49:798-802.
10. Kahan BD, Gibbons S, Tejpal N, Stepkowski SM, Chou T-C. Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro. Transplantation 1991;51:232-239.
11. Kimball PM, Kerman RH, Kahan BD. Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine. Transplantation 1991;51:486-490.
12. Flanagan WM, Corthesy B, Bram RJ, Crabtree GR. Nuclear association of a T-cell transcription factor blocked by FK 506 and cyclosporine. Nature 1991;352:803-807.
13. Dumont FJ, Staruch MJ, Koprak SL, Melino MR, Siga NH. Distinct mechanisms of suppression of murine T-cell activation by the related macrolides FK 506 and rapamycin. J Immunol 1990;144:251-258.
14. Knight R, Ferraresso M, Serino F, Katz S, Lewis R, Kahan BD. Low-dose rapamycin potentiates the effect of subtherapeutic doses of cyclosporine to prolong renal allograft survival in the mongrel canine model. Transplantation 1993;55:947-949.
15. Kahan BD, Tejpal N, Gibbons-Stubbers S, et al. The synergistic interactions in vitro and in vivo of Brequinar sodium with cyclosporine or rapamycin alone and in triple combination. Transplantation 1993;55:894-900.
16. Tu Y, Stepkowski SM, Chou T-C, Kahan BD. The synergistic effects of cyclosporine, sirolimus and Brequinar on heart allograft survival in mice. Transplantation 1995;59:177-183.
17. Sattler M, Guengerich P, Chul-.HO Yun, Christians U, Sewing KF. Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. Drug Metab Dispos 1992;20:753-761.
18. Honchari K, Fryer J, Yatscoff R. Pharmacokinetics of rapamycin: single dose studies in the rabbit. Ther Drug Monit 1992;14:475-478.
19. Yatschoff R, LeGatt D, Keenan R, Chachowsky P. Blood distribution of rapamycin. Transplantation 1993;56:1202-1206.
20. Zimmerman JJ. Assay validation report for the quantification of cyclosporine in human whole blood by the CYCLO-Trac SP radioimmunoassay. Wyeth-Ayerst GTR-25527, 1994.
21. Yeh KC, Kwan KC. A comparison of numerical integrating algorithms by trapezoidal, lagrange and spline approximation. J Pharmacokinet Biopharm 1978;6:79-98.
22. Collier D, Calne R, Thiru S, et al. Rapamycin in experimental renal allograft in dogs and pigs. Transplant Proc 1990;22:1674.
23. Granger DK, Cromwell JW, Chen SC, Goswitz JJ, Morrow DT, Beierle FA, Sehgal SN, Canafax DM, Matas AJ. Prolongation of renal allograft survival in a large animal model by oral Rapamycin monotherapy. Transplantation 1995;59:183-186.
24. Whiting PH, Woo J, Adam BJ, Hasa NU, Davidson RJ, Thompson AW. Toxicity of rapamycin - a comparative and combination study with cyclosporine at immunotherapeutic dosages in the rat. Transplantation 1991;52:203-208.
25. DiJoseph JF, Sharma RN, Chang JY. The effect of rapamycin on kidney function in the Sprague-Dawley rat. Transplantation 1992;53:507-513.
26. Golbaekdal K, Nielsen CB, Djurhuus JC, Pedersen EB. Effects of Rapamycin on renal hemodynamics, water and sodium excretion, and plasma levels of angiotensin II, aldosterone, atrial natriuretic peptide and vasopressin in pigs. Transplantation 1994;58:1153-1157.
27. Almond PS, Moss A, Nakhleh RE, et al. Rapamycin: immunosuppression, hyporesponsiveness and side-effects in a porcine renal allograft model. Transplantation 1993;56:275-281.